 Home / Osteoporosis / Rocaltrol, calcitriol |
 |
||||||||||||||||||||||||||||||||||
Buy Rocaltrol, calcitriol Buy Rocaltrol to treat osteoporosis, hypocalcaemia, rickets, and muscle cramps. The recommended initial dose of Rocaltrol is 0.25 mcg/day. If a satisfactory response in the biochemical parameters and clinical manifestations of the disease state is not observed, dosage may be increased by 0.25 mcg/day at 4 to 8 week intervals.Contraindications: Consult a doctor before taking Rocaltrol if you are pregnant or breastfeeding, if you are allergic to any of its ingredients, if you are taking any other medications (especially digoxin, cholestyramine, colestipol, mineral oil, thiazide diuretics (water pills), phenobarbital, phenytoin, steroids, vitamin D, calcium supplements, or magnesium), or if you have or have a history of heart disease, kidney disease or kidney stones, or coronary artery disease. To read more about Rocaltrol, calcitriol side effects, Rocaltrol, calcitriol dosage, and for more useful information about Rocaltrol, calcitriol, please click the product information link below.  PRODUCT INFORMATION |
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
Often prescribed for osteoporosis, hypocalcaemia, rickets, muscle cramps |
||||||||||||||||||||||||||||||||||
READ MORE ABOUT OSTEOPOROSIS
Rocaltrol, calcitriolChemical Namescalcitriol, Ingredients Active Ingredients: calcitriol Non-Active Ingredients: glycerin, parabens (methyl and propyl), sorbitol, FD&C Yellow No. 6 and titanium dioxide Indications Rocaltrol is indicated in the treatment of osteoporosis, hypocalcaemia, rickets, and muscle cramps. How It Works Calcitriol is the hormonally-active form of vitamin D. It increases the absorption of calcium from the bones and GI system to the blood, and decreases the release of calcium from the blood into the urine. All of these effects increase serum levels of calcium, which can counteract the hypocalcaemiac effects of osteoporosis Dosage Available tablet/capsule sizes: 0.25 mcg Rocaltrol therapy should always be started at the lowest possible dose and should not be increased without careful monitoring of serum calcium. The recommended initial dose of Rocaltrol is 0.25 mcg/day. If a satisfactory response in the biochemical parameters and clinical manifestations of the disease state is not observed, dosage may be increased by 0.25 mcg/day at 4 to 8 week intervals. During this titration period, serum calcium levels should be obtained at least twice weekly, and if hypercalcemia is noted, the drug should be immediately discontinued until normocalcemia ensues The effectiveness of Rocaltrol therapy is predicated on the assumption that each patient is receiving an adequate but not excessive daily intake of calcium. Patients are advised to have a dietary intake of calcium at a minimum of 600 mg daily. Because of improved calcium absorption from the gastrointestinal tract, some patients on Rocaltrol may be maintained on a lower calcium intake. Patients who tend to develop hypercalcemia may require only low doses of calcium or no supplementation at all.
Precautions |
